CGON
CG Oncology, Inc. Common stock
NASDAQ: CGON · HEALTHCARE · BIOTECHNOLOGY
$64.75
-1.22% today
Updated 2026-04-29
Market cap
$5.70B
P/E ratio
—
P/S ratio
1,410.56x
EPS (TTM)
$-2.08
Dividend yield
—
52W range
$21 – $74
Volume
1.3M
CG Oncology, Inc. Common stock (CGON) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-13.2%
Last 4 quarters
Revenue YoY growth
+409.2%
Most recent quarter
EPS YoY growth
-10.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.2%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+9.2%
2025-11-14
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-27 | $-0.51 | -6.3% | $66.67 | $63.96 | -4.1% |
| 2025-11-14 | $-0.57 | -4.3% | $37.76 | $41.25 | +9.2% |
| 2025-08-08 | $-0.54 | -22.1% | $24.35 | $23.95 | -1.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.48 | $-0.51 | -6.3% | $2.32M | +409.2% |
| 2025-09-30 | $-0.55 | $-0.57 | -4.3% | $1.67M | +3774.4% |
| 2025-06-30 | $-0.44 | $-0.54 | -22.1% | — | — |
| 2025-03-31 | $-0.37 | $-0.45 | -20.3% | $52000.00 | -90.2% |
| 2024-12-31 | $-0.45 | $-0.46 | -2.2% | $456000.00 | +45500.0% |
| 2024-09-30 | $-0.42 | $-0.30 | +28.6% | $43000.00 | — |
| 2024-06-30 | $-0.40 | $-0.28 | +30.0% | $111000.00 | — |
| 2024-03-31 | $-0.29 | $-0.36 | -24.1% | $529000.00 | — |
| 2023-12-31 | $-0.67 | $-0.33 | +50.6% | $1000.00 | — |
Frequently asked questions
Has CG Oncology, Inc. Common stock beaten earnings estimates?
CG Oncology, Inc. Common stock has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -13.2% over the last 4 quarters.
How does CGON stock react to earnings?
CGON stock has moved an average of +1.2% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is CG Oncology, Inc. Common stock's revenue growth rate?
CG Oncology, Inc. Common stock reported year-over-year revenue growth of +409.2% in its most recent quarter, with EPS growing -10.9% year-over-year.